[PDF][PDF] Consensus recommendations for optimising the diagnosis and treatment of paroxysmal nocturnal haemoglobinuria in Singapore
Introduction: Paroxysmal nocturnal haemoglobinuria (PNH) is a rare haematologic disease
characterised by intravascular haemolysis, thrombophilia and bone marrow failure. There is …
characterised by intravascular haemolysis, thrombophilia and bone marrow failure. There is …
[HTML][HTML] Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment
S Kokoris, A Polyviou, P Evangelidis, E Grouzi… - International Journal of …, 2024 - mdpi.com
Paroxysmal Nocturnal Hemoglobinuria (PNH) constitutes a rare bone marrow failure
syndrome characterized by hemolytic anemia, thrombotic events (TEs), and bone marrow …
syndrome characterized by hemolytic anemia, thrombotic events (TEs), and bone marrow …
Health-related quality of life and influencing factors of patients with paroxysmal nocturnal hemoglobinuria in China
H Yu, S Duan, P Wang, R Fu, Z Lv, Y Yu, P Miao… - Orphanet Journal of …, 2024 - Springer
Background Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder, leading
to various complications and impairments in patients' health-related quality of life (HRQOL) …
to various complications and impairments in patients' health-related quality of life (HRQOL) …
[HTML][HTML] Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria
Nano-vesicular carriers are promising tissue-specific drug delivery platforms. Here,
biomimetic proteolipid vesicles (BPLVs) were used for delivery of …
biomimetic proteolipid vesicles (BPLVs) were used for delivery of …
Safety Profile of Monoclonal Antibodies and Subsequent Drug Developments in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
V Mallenahalli Neeekantappa, A Kamath… - Medicina, 2024 - mdpi.com
Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal stem cell disease characterized by
intravascular hemolysis due to the targeting of affected red blood cells by the complement …
intravascular hemolysis due to the targeting of affected red blood cells by the complement …
Safety and efficacy of danicopan in patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis
E Muvaffak, ME Mokresh, A Varda… - Expert Review of …, 2024 - Taylor & Francis
Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease characterized by
complement-mediated intravascular hemolysis (IVH). Current treatments like Eculizumab …
complement-mediated intravascular hemolysis (IVH). Current treatments like Eculizumab …
[HTML][HTML] 浙江省289 例阵发性睡眠性血红蛋白尿症患者的临床特征
许改香， 金伟媚， 叶宝东， 江松福， 胡超… - Chinese Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
目的对浙江省阵发性睡眠性血红蛋白尿症(PNH) 患者的临床特征, 治疗现状及其生存情况进行多
中心回顾性分析, 以提高对该疾病的认识和规范化诊治水平. 方法纳入了2005 年9 月至2023 年5 …
中心回顾性分析, 以提高对该疾病的认识和规范化诊治水平. 方法纳入了2005 年9 月至2023 年5 …
The Onerous task of managing paroxysmal nocturnal hemoglobinuria in a Low resource setting: a case report. A hematologist's experience
MK Waiswa, C Sekaggya-Wiltshire, E Seremba… - African Health …, 2024 - ajol.info
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a form of red cell membrane
defect characterized by increased sensitivity to complement-mediated cell lysis, resulting in …
defect characterized by increased sensitivity to complement-mediated cell lysis, resulting in …
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043 patient/years analysis
Thrombophilia is one of the principal features of paroxysmal nocturnal hemoglobinuria
(PNH) and constitutes the main cause of disease morbidity/mortality. Anti-complement …
(PNH) and constitutes the main cause of disease morbidity/mortality. Anti-complement …
[PDF][PDF] 浙江省289 例阵发性睡眠性血红蛋白尿症患者的临床特征
姚荣欣， 陆滢， 李琳洁， 张瑾， 欧阳桂芳， 洪用伟… - pdfs.semanticscholar.org
目的对浙江省阵发性睡眠性血红蛋白尿症(PNH) 患者的临床特征, 治疗现状及其生存情况进行多
中心回顾性分析, 以提高对该疾病的认识和规范化诊治水平. 方法纳入了2005 年9 月至2023 年5 …
中心回顾性分析, 以提高对该疾病的认识和规范化诊治水平. 方法纳入了2005 年9 月至2023 年5 …